Silence Therapeutics confirms reverse merger talks
29 September 2009
Sukaina Virji
The UK RNAi company
Silence Therapeutics has confirmed it is in merger discussions with an unnamed company.
It expects the proposed transaction to be treated as a reverse takeover – a move that allows privately held companies to get a stock market listing without having to conduct an initial public...
Please Login to read the full article.
29 September 2009
Sukaina Virji
It expects the proposed transaction to be treated as a reverse takeover – a move that allows privately held companies to get a stock market listing without having to conduct an initial public...
Please Login to read the full article.
RELATED CONTENT
NEWS
- Quark's siRNA again fails to charm public market: withdraws IPO offer
- Allozyne finds route to going public via merger with troubled Poniard and its anticancer picoplatin
- Benitec recapitalising after US patent resolution opens up new opportunities
- Weaker private equity in India for 2012, portfolios turning 'a la carte'
COMMENT
Other Informa Comment
EVENTS
Today
London
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
